300030 阳普医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-6.059-8.386-22.2241.85717.706
总资产报酬率 ROA (%)-3.085-4.236-11.7231.0409.996
投入资产回报率 ROIC (%)-3.616-5.053-13.7311.20111.573

边际利润分析
销售毛利率 (%)40.04340.38337.20240.82346.809
营业利润率 (%)-9.699-6.331-29.9453.73618.057
息税前利润/营业总收入 (%)-7.973-4.143-27.9776.14121.056
净利润/营业总收入 (%)-10.590-9.342-27.1952.47217.767

收益指标分析
经营活动净收益/利润总额(%)-18.23971.59519.605124.21877.594
价值变动净收益/利润总额(%)116.509-17.28524.777112.69054.225
营业外收支净额/利润总额(%)1.1165.2220.679-25.352-0.545

偿债能力分析
流动比率 (X)1.1581.1011.1251.2451.851
速动比率 (X)0.9070.8820.9071.0221.526
资产负债率 (%)46.07246.53947.33543.5400.425
带息债务/全部投入资本 (%)36.75735.61033.71131.70528.729
股东权益/带息债务 (%)161.738168.199179.772197.899232.239
股东权益/负债合计 (%)110.994108.960106.343125.869134.744
利息保障倍数 (X)-4.343-1.633-12.8741.9436.799

营运能力分析
应收账款周转天数 (天)110.981114.479112.958118.620104.005
存货周转天数 (天)142.400127.291117.335115.07585.498